Atara Biotherapeutics: Q2 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a second-quarter loss of $4.8 million, after reporting a profit in the same period a year earlier.

The Thousand Oaks, California-based company said it had a loss of 32 cents per share.

The drug developer posted revenue of $630,000 in the period.

Atara Biotherapeutics shares have declined 50% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $9, a drop of 22% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA